＜研究開発・メディカルアフェアーズ統括本部＞ニューロサイエンス領域　臨床開発医師（Clinical research physician）（脳神経内科医・脳神経外科医・精神科医募集）/神戸本社・東京支社（応相談） at Eli Lilly and Company

Kobe, Hyogo, Japan

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, NeuroscienceIndustries

Requirements

Japanese Medical License (with >5 years of clinical experience)
Specialty in Neurology, Psychiatry, or Neurosurgery, with a specialization in neuroscience, particularly in neurodegenerative diseases (Alzheimer’s disease included), mental disorders, or pain (neuropathic pain included)
Several years of experience in writing scientific papers
Demonstrated ability to lead and manage teams effectively
Excellent communication skills, both internally and externally, with the ability to build relationships with diverse stakeholders
Business-level proficiency in both English and Japanese
Strong presentation skills
Strategic and logical thinking skills

Responsibilities

Lead/support clinical development activities in collaboration with relevant departments
Provide support for clinical trial implementation
Lead the preparation of application materials for regulatory submissions
Lead medical affairs activities, including key opinion leader engagement, information sharing, and relationship building
Lead activities related to preparing for the launch of new drugs
Contribute to the planning of medical events (e.g., advisory board meetings)
Develop and implement strategies for medical education activities (e.g., organizing and running educational conferences, creating educational materials)
Develop scientific evidence (e.g., real-world evidence generation)
Lead the preparation of scientific presentations and publications, including collaboration with key opinion leaders
Engage with external customers (including key opinion leaders) in discussions regarding the drug
Respond to medical and scientific inquiries from external customers (e.g., preparing responses, conducting site visits)
Develop strategies to enhance product value after market launch, in collaboration with the sales/marketing team

Skills

Neurology

Psychiatry

Neurosurgery

Clinical Development

Clinical Trials

Regulatory Submissions

Medical Affairs

KOL Engagement

Scientific Writing

Team Leadership

Stakeholder Management

Presentation Skills

Strategic Thinking

English Proficiency

Japanese Proficiency

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free